Cargando…

Association of HLA-DR/DQ polymorphisms with schizophrenia in Tunisian patients

BACKGROUND AND OBJECTIVES: The hypothesis that human leukocyte antigens (HLAs) confer susceptibility to schizophrenic disorders has been tested by studying linkage and association in family samples. Our goal was to evaluate the role of HLA in the risk of developing schizophrenia in a Tunisian popula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayeh, Aicha, Ben Cheikh, Cheker, Mrad, Meriem, Lakhal, Najwa, Gritli, Nasreddine, Galelli, Slaheddine, Oumaya, Abdelaziz, Fekih-Mrissa, Najiba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	King Faisal Specialist Hospital and Research Centre 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074579/ https://www.ncbi.nlm.nih.gov/pubmed/25971824 http://dx.doi.org/10.5144/0256-4947.2014.503

Ejemplares similares

HLA DRB1*03 as a possible common etiology of schizophrenia, Graves’ disease, and type 2 diabetes
por: Sayeh, Aicha, et al.
Publicado: (2017)

Association between an angiotensin-converting enzyme gene polymorphism and Alzheimer’s disease in a Tunisian population
por: Fekih-Mrissa, Najiba, et al.
Publicado: (2017)

Cerebral venous thrombosis associated with homozygous factor V Leiden mutation in a 15-year-old girl of Tunisian origin
por: Salem-Berrabah, Olfa Ben, et al.
Publicado: (2011)

Association of FV G1691A Polymorphism but not A4070G With Coronary Artery Disease
por: Amara, Ahmed, et al.
Publicado: (2017)

Combination of factor V Leiden and MTHFR mutations in myocardial infarction
por: Fekih-Mrissa, Najiba, et al.
Publicado: (2013)

Peptide binding predictions for HLA DR, DP and DQ molecules
por: Wang, Peng, et al.
Publicado: (2010)

Immunogenetic Study of Diabetes Mellitus in Relation to HLA DQ and DR
por: Singh, Gyanendra, et al.
Publicado: (2020)

Limbic encephalitis associated with leucine-rich glioma-inactivated 1 antibodies
por: Messelmani, Mariem, et al.
Publicado: (2015)

HLA class I (-A, -B, -C) and class II (-DR, -DQ) polymorphism in the Mauritanian population
por: Hamed, Cheikh Tijani, et al.
Publicado: (2018)

Associations of HLA DR and DQ molecules with Lyme borreliosis in Latvian patients
por: Kovalchuka, Lilija, et al.
Publicado: (2012)

The incidence of HLA-DQ2/DQ8 in Turkish children with celiac disease and a comparison of the geographical distribution of HLA-DQ
por: Basturk, Ahmet, et al.
Publicado: (2017)

HLA-DQ2 and -DQ8 genotype frequency in Syrian celiac disease children: HLA-DQ relative risks evaluation
por: Murad, Hossam, et al.
Publicado: (2018)

HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity
por: Wiebe, Chris, et al.
Publicado: (2018)

HLA-DR and HLA-DQ alleles in patients from the south of Brazil: markers for leprosy susceptibility and resistance
por: da Silva, Samira A, et al.
Publicado: (2009)

Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ
por: Hrdinová, Johana, et al.
Publicado: (2018)

HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes
por: Bezstarosti, Suzanne, et al.
Publicado: (2022)

Human hematopoietic progenitor cells in long-term cultures express HLA- DR antigens and lack HLA-DQ antigens
Publicado: (1985)

The HLA-B*3906 allele imparts a high risk of diabetes only on specific HLA-DR/DQ haplotypes
por: Baschal, E. E., et al.
Publicado: (2011)

Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells
por: Peyron, Ivan, et al.
Publicado: (2018)

HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity
por: Lundgren, Hanna, et al.
Publicado: (2017)

Assessing the Prevalence of HLA-DQ2 and HLA-DQ8 in Lipedema Patients and the Potential Benefits of a Gluten-Free Diet
por: Amato, Alexandre C, et al.
Publicado: (2023)

THE PREVALENCE OF HLA DQ2 AND DQ8 IN PATIENTS WITH CELIAC DISEASE, IN FAMILY AND IN GENERAL POPULATION
por: CECILIO, Lucila Arantes, et al.
Publicado: (2015)

Meta-Analysis and Systematic Review of HLA DQ2/DQ8 in Adults with Celiac Disease
por: Aboulaghras, Sara, et al.
Publicado: (2023)

The association of HLA-DR/DQ coding and QBP promoter allelic polymorphism with antiphospholipid antibody response in SLE
por: Logar, D, et al.
Publicado: (2002)

The Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ Genotype
por: Reinauer, Christina, et al.
Publicado: (2017)

Association of IL-4RA single nucleotide polymorphisms, HLA-DR and HLA-DQ in children with Alternaria-sensitive moderate-severe asthma
por: Knutsen, Alan P, et al.
Publicado: (2010)

Definition of High-Risk Type 1 Diabetes HLA-DR and HLA-DQ Types Using Only Three Single Nucleotide Polymorphisms
por: Nguyen, Cao, et al.
Publicado: (2013)

Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition
Publicado: (1990)

Estimation of Diabetes Risk in Brazilian Population by Typing for Polymorphisms in HLA-DR-DQ, INS and CTLA-4 Genes
por: Hauache, Omar M., et al.
Publicado: (2005)

RFLP Analysis of HLA-DRβ and -DQβ Genes in the Korean Patients with Insulin-Dependent Diabetes Mellitus
por: Lee, Hong Kyu, et al.
Publicado: (1989)

Vaccination coverage against COVID-19 in a Tunisian general hospital
por: Kefi, Hamdi El, et al.
Publicado: (2021)

HLA-A, B (Class I) and HLA-DR, DQ (Class II) Antigens in Turkish Patients with Recurrent Aphthous Ulceration and Behçet's Disease
por: Pekiner, Filiz Namdar, et al.
Publicado: (2013)

Evaluation of HLA-DQ2/DQ8 genotype in patients with celiac disease hospitalised in 2012 at the Department of Paediatrics
por: Szałowska-Woźniak, Dorota A., et al.
Publicado: (2014)

Human Leukocyte Antigen DQ (HLA‐DQ) genotypes and haplotypes and their association with phenotype in patients with celiac disease in India
por: Ramakrishna, Balakrishnan S, et al.
Publicado: (2021)

Covid-19 induced blood supply shortage: A Tunisian blood deposit perspective()
por: Hammami, Emna, et al.
Publicado: (2022)

A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes
por: Parry, Christian S, et al.
Publicado: (2008)

Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes
por: Hannelius, Ulf, et al.
Publicado: (2020)

Low Hydrophobic Mismatch Scores Calculated for HLA-A/B/DR/DQ Loci Improve Kidney Allograft Survival
por: Bekbolsynov, Dulat, et al.
Publicado: (2020)

Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2
por: Nowak, Christoph, et al.
Publicado: (2022)

HLA-DQ: Celiac disease vs inflammatory bowel disease
por: Bosca-Watts, Marta Maia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_he973r5c35hhd0b5b80idk9vqc